America Great Health (AAGH) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US02365T1016
America Great Health financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 294,670.00 USD | 391,743.00 USD |
| Gross profit | 169,750.00 USD | 339,121.00 USD |
| Operating income | -782,700.00 USD | -382,935.00 USD |
| EBIT | -382,935.00 USD | – |
| Net income | -1.22 m USD | -721,242.00 USD |
| Diluted EPS – continuing operations | 0.00 USD | – |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About America Great Health
America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.
More stocks
- Sports Entertainment Gaming Global Corp (SEGG)
- enVVeno Medical Corp (NVNO)
- Blue Star Foods Corp. (BSFC)
- DataMeds AI, Inc. (MEDS)
- TaoWeave, Inc. (TWAV)
- Bio Green Med Solution, Inc. (BGMS)
- CNS Pharmaceuticals, Inc. (CNSP)
- CaliberCos Inc. (CWD)
- Advanced Biomed Inc. (ADVB)
- OLB GROUP, INC. (OLB)
- Cyngn Inc. (CYN)
- MKDWELL Tech Inc. Ordinary Share (MKDW)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.